Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

22 та иш

Иш: Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

    Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

    МақолаTuberculosis Research and EpidemiologyEurosurveillance201315 иқтибос
    ABI

  2. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    Мақола201011 иқтибос
    ABI

  3. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

    Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

    Мақола20146 иқтибос
    ABI

  4. The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis

    Dennis Falzon, Ernesto Jaramillo, Holger J. Schünemann

    Мақола20115 иқтибос
    ABI

  5. Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

    K. J. M. Aung, Armand Van Deun, Erik De Clercq +4

    Мақола20145 иқтибос
    ABI

  6. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

    Christopher Kuaban, J Noeske, Hans L. Rieder +3

    Мақола20155 иқтибос
    ABI

  7. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

    Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch +13

    Мақола20144 иқтибос
    ABI

  8. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

    Catharina Boehme, Pamela Nabeta, Doris Hillemann +16

    Мақола20104 иқтибос
    ABI

  9. Evaluation of the Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens

    Elizabeth M. Marlowe, Susan Novak-Weekley, Joven Cumpio +6

    Мақола20112 иқтибос
    ABI

  10. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

    Evan Orenstein, Sanjay Basu, N. Sarita Shah +5

    Шарҳ мақола20092 иқтибос
    ABI

  11. Research Protocol - Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan

    Philipp du Cros, Khamraev Atadjan, Mirzagalib Tillashaikhov +19

    Мақола20142 иқтибос
    ABI

  12. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

    Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt +16

    Мақола20152 иқтибос
    ABI

  13. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

    Andrew Nunn, I. D. Rusen, Armand Van Deun +6

    Мақола20142 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI